Speaker illustration

Doctor David Antonio Chipayo Gonzales

University Hospital Complex of Caceres, Caceres (Spain)

Member of:

European Society of Cardiology

Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease

Event: ESC Congress 2022

Topic: Antidiabetic Pharmacotherapy

Session: SGLT2 inhibitors in clinical practice


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb